EYEFI Group Technologies Inc.
EGTI.CN News Today: Stay Updated with the Latest EYEFI Group Technologies Inc. News in Real Time
Find EGTI.CN news now at Meyka AI. Stay informed with the latest EYEFI Group Technologies Inc. stocks updates, including price news, market analysis, and expert insights.
Sky Quarry (SKYQ) NASDAQ close $5.10 on 02 Apr 2026: Apr 7 earnings could reset valuation
SKYQ stock closed at $5.10 on 02 Apr 2026 ahead of Apr 7 earnings; our SKYQ stock outlook highlights valuation and risks
ASWN.SW stock up 9.82% pre-market at CHF 0.62: catalysts and price targets
ASWN.SW stock jumps 9.82% pre-market to CHF 0.62 on SIX; quick analysis, valuation and Meyka AI forecast for ASWN.SW stock
03 Apr 2026 JPX Pre-Market Top Gainer: 6597.T HPC SYSTEMS at JPY 2098, watch targets
Pre-market top gainer 6597.T stock up 23.56% to JPY 2098 on JPX; analysis, Meyka grade and model forecast
03 Apr 2026 pre-market VTG.AX Vita Group ASX +79.57% on 3.95M: liquidity signal
VTG.AX stock jumps 79.57% pre-market to A$0.145 on heavy volume; analysis, Meyka grade and forecast for VTG.AX stock
NKE Stock Today April 03: BofA, Telsey Cut PT to $55 on Slower Recovery
Nike share price dips as BofA and Telsey cut price targets to $55 with Neutral/Market Perform calls. See what this means for SG investors, key levels, and next catalysts.
Kasumigaseki Capital (3498.T JPX) pre-market JPY 6,500.00: earnings drive next steps
Pre-market earnings spotlight on 3498.T stock at JPX. Price JPY 6,500.00, EPS JPY 512.26, Meyka AI forecast and grade
Pre-market top loser: CDW Holding (BXE.SI) -7.53% to S$0.086: key support S$0.07
BXE.SI stock falls to S$0.086 in pre-market; Meyka AI forecast shows downside to S$0.06 quarterly. Read the analysis and price targets
CSCI.TO COSCIENS Biopharma (TSX) up 90.08% intraday 02 Apr 2026: catalyst, outlook
Intraday: CSCI.TO stock jumps 90.08% to C$2.30 on 02 Apr 2026; volume surge and Meyka forecast analysis
Leapmotor April 02: CEO, Founder Buy HK$230M in H-shares, Stake Rises
Leapmotor share purchase: CEO Zhu Jiangming and Fu Liquan bought HK$230M of Hong Kong H-shares, lifting their group stake to 23.89%. What this signals for Canadian investors, near‑term catalysts, key